A note from history: Landmarks in history of cancer, Part 6

@article{Hajdu2013ANF,
  title={A note from history: Landmarks in history of cancer, Part 6},
  author={Steven I. Hajdu and Manjunath S. Vadmal},
  journal={Cancer},
  year={2013},
  volume={119}
}
In the 3 decades from 1940 to 1970, the United States became the nucleus for research, diagnosis, and treatment of cancer. The discovery of anticancer drugs, and the clinical demonstration that chemotherapy and radiation can cure cancer and have the ability to prevent recurrence of cancer, were incontrovertibly the most remarkable groundbreaking events. Consequently, the trend of less surgery and more multimodality therapy began. The introduction of radioautography, mammography, ultrasonography… 
A note from history: Landmarks in history of cancer, part 7
TLDR
The 25 years from 1970 and 1995 are the high‐water mark in clinical oncology, and this is the period when oncological turned from art to science, and the decline in cancer incidence and mortality demonstrated that cancer prevention and advancement in oncologists are pivotal to success in the crusade against cancer.
Pathfinders in oncology from the beginning of modern surgery of intracranial tumors to the introduction of the Pap smear
TLDR
During the period from 1922 to 1942, several carcinogens were identified in coal tar, industrial oils, and petroleum, and radium was added to x‐ray as a potential carcinogen, and the dependency of prostatic and mammary hyperplasia and carcinoma on naturally occurring hormones was established.
Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography
During the period from 1942 to 1962, treatment attempts with single‐agent chemotherapy such as nitrogen mustard and urethan gained limited application. However, the groundbreaking success with
Pathfinders in oncology from the time the causal relation between tobacco use and lung cancer was established to publication of the first Cancer Staging Manual by the American Joint Committee on Cancer
TLDR
During the period from 1962 to 1977, several antigens, notably carcinoembryonic antigen and prostate‐specific antigen, were discovered and entered clinical use and radioimmunoassay and immunohistochemistry techniques were standardized.
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
TLDR
Today, cancer research is always aimed at the study and development of new therapeutic approaches for cancer treatment, and several researchers are focused on the development of cell therapies, anti-tumor vaccines, and new biotechnological drugs that have already shown promising results in preclinical studies, therefore, in the near future, it will certainly assist to a new revolution in the field of medical oncology.
Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution
TLDR
This article comprises a series of clinical trials that utilized kinase inhibitors (KIs) as a monotherapy or in combination with other cytotoxic agents to treat patients afflicted with solid tumors, with varying degrees of efficacy.
Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response and Resistance to Chemotherapy
TLDR
By integrating sphingolipid signaling into the molecular characterization of breast tumors, new opportunities for targeted intervention are identified and it is increasingly apparent that modulating sphingoipid levels in tumors will be an effective and powerful method for the treatment of breast cancer.
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations
TLDR
Overall, regimens of KI treatment are clinically manageable, and results are especially effective when allied with tumor genetic profiles, giving rise to encouraging future prospects of an era where chemotherapy-free treatment regimens are a reality for many oncologic patients.
Fibromyxoma of the Jaw: Case Report and Review of the Literature
TLDR
A patient presented in the first trimester of pregnancy with a large mass in the right body of the mandible exhibiting displacement of teeth and destruction of an extensive area of theMandibular bone, which dictated a wide mandibular resection.
...
1
2
3
...

References

SHOWING 1-10 OF 435 REFERENCES
A note from history: Landmarks in history of cancer, part 5
TLDR
With all the advances in the diagnosis and treatment of cancers, very little betterment could be demonstrated in the overall survival of patients, and by the end of the 1930s, cancer became the second most common cause of death in the United States.
A note from history: Landmarks in history of cancer, part 4
TLDR
The 50 years covered in this review formed the groundwork for the coordinated, specialized care of cancer patients at institutions dedicated to render the most promising treatment.
The first editor of Cancer and his contribution to oncology
TLDR
The year 1948 signaled the beginning of the end for treating patients without a biopsy-proven diagnosis, and there was an urgent need for a peer-reviewed journal for communication among physicians who cared for cancer patients, only 1 issue remained unresolved: who should be the Editor of the new journal, Cancer.
A note from history: Landmarks in history of cancer, part 3
TLDR
Preoperative microscopic diagnoses and classification of cancers in biopsy specimens were incorporated into choosing the most fitting surgical operation by surgeons by the mid‐1800s.
Experience with mammography in a tumor institution. Evaluation of 1,000 studies.
TLDR
No satisfactory statistical analysis of consecutive mammograms in patients with adequate follow-up has appeared in the American literature, and the method of examination, soft-tissue roentgenography of the breast, is not new.
The surgical treatment of cancer of the cervix uteri.
Foundation of diagnostic cytology.
TLDR
The history of diagnostic cytology is like a winding road with many obstacles, but to the attentive traveler–the historian–brightly illuminated directional signs and familiar names are visible in the distance; there were four great technical advances that gave impetus to microscopic examination of tumor cells in smear preparations.
Anatomic distribution and grading of carcinoma in situ of the cervix
TLDR
The grading of CIS on cone biopsies according to this method may effect a re‐evaluation of the indications for hysterectomy in which the cone biopsy itself may constitute final therapy.
Papillary adenoma of the large intestine
Received March 31, 1998; accepted April 1, 1998. In the July issue of the first volume of Cancer, Sunderland and Binkley provided the readership with a comprehensive, meticulous, and beautifully
...
1
2
3
4
5
...